Autolus Therapeutics PLC (NAS:AUTL)
$ 3.26 -0.06 (-1.81%) Market Cap: 867.56 Mil Enterprise Value: 278.69 Mil PE Ratio: 0 PB Ratio: 1.82 GF Score: 58/100

Q4 2022 Autolus Therapeutics PLC Earnings Call Transcript

Mar 07, 2023 / 01:30PM GMT
Release Date Price: $1.92 (+0.52%)
Operator

Ladies and gentlemen, and welcome to the Autolus Therapeutics Full Year 2022 Financial Results Conference Call and Fourth Quarter Operational Progress. As a reminder, this conference is being recorded.

I would now like to turn the conference over to your host, Julia Wilson, Communications Consultant. Please go ahead.

Julia Wilson

Thank you, Norma. Good morning or good afternoon, everyone, and thank you for joining us to take part in today's call on the full year 2022 financial results and operational highlights for the fourth quarter 2022. I'm Julia Wilson, the Communications Consultant for Autolus. With me today are Dr. Christian Itin, our Chief Executive Officer; and Dr. Lucinda Crabtree, our Chief Financial Officer.

Before we begin, I would like to remind you that during today's call we will make statements related to our business that are forward-looking under federal securities laws and the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These may include but are not limited to statements regarding the status of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot